News For Eli Lilly


This RSS feed URL is deprecated

This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
Google 9/20/2018 4:14:51 PM

Lilly's Elanco Rises After $1.5 Billion Animal-Health IPO - Bloomberg


Bloomberg

Lilly's Elanco Rises After $1.5 Billion Animal-Health IPO
Bloomberg
The Eli Lilly & Co.-owned animal medicine maker rose to $32.11 from its $24 offering price at 11:40 a.m. Thursday in New York trading, giving it a market value of $11.7 billion. It rose as high $33.20 before settling. Elanco priced 62.9 million shares ...
Eli Lilly's Animal Health Unit Elanco Raises $1.5B In IPOLaw360
Lilly's Elanco animal health unit's IPO priced at $24/shareReuters
Elanco Begins IPOInside INdiana Business
Indianapolis Business Journal -Markets Insider -Business Wire
all 46 news articles »
Google 9/20/2018 3:57:55 PM

Eli Lilly And Co (LLY) Shares Bought by Ashburton Jersey Ltd - Fairfield Current


Post Analyst

Eli Lilly And Co (LLY) Shares Bought by Ashburton Jersey Ltd
Fairfield Current
Ashburton Jersey Ltd lifted its stake in shares of Eli Lilly And Co (NYSE:LLY) by 8.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,185 shares of the company's ...
Analysts Have Differing Views On Eli Lilly and Company (LLY), Momo Inc. (MOMO)Post Analyst
Stock Analysis Under a Powerful Visual Trend-Spotting Tool – Eli Lilly and Company (NYSE: LLY)Alpha Beta Stock
Eli Lilly and Company (LLY) is at $105.74 per share and Novo Nordisk A/S (NVO) is listed at $47.00Stocks Gallery
Baseball Daily News -Marea Informative (blog) -Hot Stock Spotter
all 51 news articles »
Google 9/20/2018 3:03:13 PM

Eli Lilly Prices Animal Health Unit IPO at $24 Per Share - Zacks.com


Zacks.com

Eli Lilly Prices Animal Health Unit IPO at $24 Per Share
Zacks.com
With the IPO of 62.9 million shares of Elanco's common stock, Lilly will raise up to $1.5 billion from the divestiture of a minority stake in the company. Lilly is expected to own a stake of approximately 82.3% in the new company, Elanco Animal Health ...
IPO Coverage: Elanco Animal Health (ELAN)Forbes
Animal health firm Elanco surges 36 percent in debutReuters
Elanco Animal Health stock soars more than 35% in trading debutMarketWatch
WISH-TV
all 27 news articles »
Google 9/20/2018 2:02:42 PM

Should You Be Holding Eli Lilly and Company (NYSE:LLY)? - Simply Wall St


Simply Wall St

Should You Be Holding Eli Lilly and Company (NYSE:LLY)?
Simply Wall St
I've been keeping an eye on Eli Lilly and Company (NYSE:LLY) because I'm attracted to its fundamentals. Looking at the company as a whole, as a potential stock investment, I believe LLY has a lot to offer. Basically, it is a financially-healthy company ...
Pharma Stocks: Eli Lilly's Revenue Trend and 2018 EstimatesMarket Realist
Eli Lilly And Co (LLY) Shares Bought by Waverton Investment Management LtdFairfield Current
Fascinating Stocks: Neptune Technologies & Bioressources Inc., (NASDAQ: NEPT), Eli Lilly and Company, (NYSE: LLY)Nyse Trading News (press release)
Post Analyst -AppsforPCdaily -SEC.gov -SEC.gov
all 201 news articles »
Google 9/18/2018 3:02:11 PM

Eli Lilly Is Selling More Shares of This Biopharma Firm - Barron's


Barron's

Eli Lilly Is Selling More Shares of This Biopharma Firm
Barron's
Eli Lilly(LLY) continues to trim its stake in Zymeworks(ZYME). After selling $508,000 of Zymeworks shares in August, Lilly this week sold another $681,130 of shares of the Vancouver-based biopharmaceutical firm. Lilly sold a total of 46,736 Zymeworks ...
Sentinel Trust Co. LBA Decreases Position in Eli Lilly And Co (LLY)Fairfield Current
Gratifying Stocks: Ctrip.com International, Ltd., (NASDAQ: CTRP), Eli Lilly and Company, (NYSE: LLY)Nyse Trading News (press release)
Eli Lilly and Company Risk Points versus Health CareCML News
NMSU Nеws -Global Export Lines (press release) -Top Stocks News (press release) -SEC.gov
all 139 news articles »
Google 9/14/2018 9:12:09 PM


Eli Lilly's PET imaging agent successful in late-stage study - Seeking Alpha


Eli Lilly's PET imaging agent successful in late-stage study
Seeking Alpha
A Phase 3 clinical trial evaluating the effectiveness of Eli Lilly (LLY +1.3%) unit Avid Radiopharmaceuticals' PET imaging agent flortaucipir F 18 met the primary sensitivity and specificity endpoints for detecting tau protein neurofibrillary tangles ...

and more »
Google 9/5/2018 7:23:07 PM

 1 2